Removal of the antiviral agent oseltamivir and its biological activity by oxidative processes

Environmental Pollution

Volumn 161, Issue , 2012, Pages 30-35

  Mestankova, Hana ^a   Schirmer, Kristin ^a,b,c   Escher, Beate I ^a,d   Von Gunten, Urs ^a,b,c   Canonica, Silvio ^a  

^a SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY   (Switzerland)

^b EPFL   (Switzerland)

^c ETH ZURICH   (Switzerland)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Degradation; Hydroxyl radical; Neuraminidase inhibitory activity; Ozone; Tamiflu

Indexed keywords

ACTIVE METABOLITES; ADVANCED OXIDATION PROCESSES; ANTIVIRAL ACTIVITIES; ANTIVIRAL AGENTS; HIGH CONCENTRATION; HIGHER-DEGREE; HYDROXYL RADICALS; KINETIC MEASUREMENT; NEURAMINIDASE; OSELTAMIVIR; OXIDATIVE PROCESS; PANDEMIC INFLUENZA; SECOND-ORDER RATE CONSTANTS; TAMIFLU; WASTEWATER TREATMENT PLANT EFFLUENT;

DEGRADATION; EFFLUENT TREATMENT; OZONE; OZONE WATER TREATMENT; OZONIZATION; RATE CONSTANTS; WASTEWATER; WASTEWATER TREATMENT;

EFFLUENTS;

OSELTAMIVIR;

CONCENTRATION (COMPOSITION); DEGRADATION; HYDROXYL RADICAL; OXIDATION; OZONE; PH; REACTION KINETICS; WASTEWATER;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG TRANSFORMATION; ENZYME INHIBITION; OZONATION; PH; REACTION ANALYSIS; WASTE COMPONENT REMOVAL;

ANTIVIRAL AGENTS; OSELTAMIVIR; OXIDATION-REDUCTION; OZONE; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

EID: 80054736627     PISSN: 02697491     EISSN: 18736424     Source Type: Journal    
DOI: 10.1016/j.envpol.2011.09.018     Document Type: Article

References (41)

1. C. Accinelli, A. Barra Caracciolo, and P. Grenni Degradation of the antiviral drug oseltamivir carboxylate in surface water samples International Journal of Environmental Analytical Chemistry 87 2007 579 587 (Pubitemid 46868183)
2. ®) and other selected pharmaceuticals from wastewater using a granular bioplastic formulation entrapping propagules of phanerochaete chrysosporium Chemosphere 81 2010 436 443
3. C. Accinelli, M.L. Sacc, J. Fick, M. Mencarelli, R. Lindberg, and B. Olsen Dissipation and removal of oseltamivir (Tamiflu) in different aquatic environments Chemosphere 79 2010 891 897
4. J.L. Acero, and U. von Gunten Characterization of oxidation processes: ozonation and the AOP O3/H2O2 Journal/American Water Works Association 93 2001 90 100 (Pubitemid 33700998)
5. P. Bartels, and W. von Tümpling The environmental fate of the antiviral drug oseltamivir carboxylate in different waters Sci. Total Environ 405 2008 215 225
6. M.C. Dodd, M.-O. Buffle, and U. von Gunten Oxidation of antibacterial molecules by aqueous ozone: moiety-specific reaction kinetics and application to ozone-based wastewater treatment Environmental Science & Technology 40 2006 1969 1977
7. M.C. Dodd, H.-P.E. Kohler, and U. von Gunten Oxidation of antibacterial compounds by ozone and hydroxyl radical: elimination of biological activity during aqueous ozonation processes Environmental Science & Technology 43 2009 2498 2504
8. P. Dowideit, and C. von Sonntag Reaction of ozone with ethene and its methyl- and chlorine-substituted derivatives in aqueous solution Environmental Science & Technology 32 1998 1112 1119 (Pubitemid 28208298)
9. C. D'Souza, M. Kanyalkar, M. Joshi, E. Coutinho, and S. Srivastava Probing molecular level interaction of oseltamivir with H5N1-NA and model membranes by molecular docking, multinuclear NMR and DSC methods Biochimica et Biophysica Acta (BBA) - Biomembranes 1788 2009 484 494
10. J.B. Ellis Antiviral pandemic risk assessment for urban receiving waters Water Science and Technology 2010 879 884
11. M.S. Elovitz, U. von Gunten, and H.P. Kaiser Hydroxyl radical/ozone ratios during ozonation processes. II. The effect of temperature, pH, alkalinity, and DOM properties Ozone Sci. Eng 22 2000 123 150 (Pubitemid 30300944)
12. ® (oseltamivir ethylester) and its active metabolite oseltamivir acid Aquatic Toxicology 96 2010 194 202
13. J. Fick, R.H. Lindberg, M. Tysklind, P.D. Haemig, J. Waldenström, A. Wallensten, and B. Olsen Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus PLoS ONE 2 2007 e986
14. G.C. Ghosh, N. Nakada, N. Yamashita, and H. Tanaka Occurrence and fate of oseltamivir carboxylate (Tamiflu) and amantadine in sewage treatment plants Chemosphere 81 2010 13 17
15. G.C. Ghosh, N. Nakada, N. Yamashita, and H. Tanaka Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (tamiflu), detected in sewage discharge and river water in Japan Environmental Health Perspectives 118 2010 103 107
16. C. Gonalves, S. Pérez, V. Osorio, M. Petrovic, M.F. Alpendurada, and D. Barceló Photofate of oseltamivir (Tamiflu) and oseltamivir carboxylate under natural and simulated solar irradiation: kinetics, identification of the transformation products, and environmental occurrence Environmental Science & Technology 45 2011 4307 4314
17. G. He, J. Massarella, and P. Ward Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802 Clinical Pharmacokinetics 37 1999 471 484 (Pubitemid 30032251)
18. T. Heberer Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data Toxicology Letters 131 2002 5 17 (Pubitemid 34461906)
19. J. Hollender, S.G. Zimmermann, S. Koepke, M. Krauss, C.S. McArdell, C. Ort, H. Singer, U. von Gunten, and H. Siegrist Elimination of organic micropollutants in a municipal wastewater treatment plant upgraded with a full-scale post-ozonation followed by sand filtration Environmental Science & Technology 43 2009 7862 7869
20. M.M. Huber, S. Canonica, G.-Y. Park, and U. von Gunten Oxidation of pharmaceuticals during ozonation and advanced oxidation processes Environmental Science & Technology 37 2003 1016 1024 (Pubitemid 36504805)
21. M.M. Huber, A. Göbel, A. Joss, N. Hermann, D. Löffler, C.S. McArdell, A. Ried, H. Siegrist, T.A. Ternes, and U. von Gunten Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study Environmental Science & Technology 39 2005 4290 4299 (Pubitemid 40770262)
22. ®) under pandemic use conditions to the coastal marine compartment Environment International 35 2009 931 936
23. H.J. Jeong, Y.B. Ryu, S.-J. Park, J.H. Kim, H.-J. Kwon, J.H. Kim, K.H. Park, M.-C. Rho, and W.S. Lee Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities Bioorganic & Medicinal Chemistry 17 2009 6816 6823
24. I.A. Katsoyiannis, S. Canonica, and U. von Gunten Efficiency and energy requirements for the transformation of organic micropollutants by ozone, O3/H2O2 and UV/H2O2 Water Research 45 2011 3811 3822
25. C.U. Kim, W. Lew, M.A. Williams, H. Liu, L. Zhang, S. Swaminathan, N. Bischofberger, M.S. Chen, D.B. Mendel, C.Y. Tai, W.G. Laver, and R.C. Stevens Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity Journal of the American Chemical Society 119 1997 681 690 (Pubitemid 27101232)
26. Y. Lee, and U. von Gunten Oxidative transformation of micropollutants during municipal wastewater treatment: comparison of kinetic aspects of selective (chlorine, chlorine dioxide, ferrateVI, and ozone) and non-selective oxidants (hydroxyl radical) Water Research 44 2010 555 566
27. Y. Lee, B.I. Escher, and U. von Gunten Efficient removal of estrogenic activity during oxidative treatment of waters containing steroid estrogens Environmental Science & Technology 42 2008 6333 6339
28. A. Leitzke, E. Reisz, R. Flyunt, and C. von Sonntag The reactions of ozone with cinnamic acids: formation and decay of 2-hydroperoxy-2-hydroxyacetic acid Journal of the Chemical Society, Perkin Transactions 2 2001 793 797
29. H. Mestankova, B. Escher, K. Schirmer, U. von Gunten, and S. Canonica Evolution of algal toxicity during (photo)oxidative degradation of diuron Aquatic Toxicology 101 2011 466 473
30. A. Nikolaou, S. Meric, and D. Fatta Occurrence patterns of pharmaceuticals in water and wastewater environments Analytical and Bioanalytical Chemistry 387 2007 1225 1234 (Pubitemid 46220407)
31. M. Potier, L. Mameli, M. Bélisle, L. Dallaire, and S.B. Melanon Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-[alpha]- N-acetylneuraminate) substrate Analytical Biochemistry 94 1979 287 296 (Pubitemid 9173017)
32. C. Prasse, M.P. Schlüsener, R. Schulz, and T.A. Ternes Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance? Environmental Science & Technology 44 2010 1728 1735
33. M.L. Sacc, C. Accinelli, J. Fick, R. Lindberg, and B. Olsen Environmental fate of the antiviral drug Tamiflu in two aquatic ecosystems Chemosphere 75 2009 28 33
34. A.C. Singer, M.A. Nunn, E.A. Gould, and A.C. Johnson Potential risks associated with the proposed widespread use of Tamiflu Environmental Health Perspectives 115 2007 102 106 (Pubitemid 46050289)
35. A.C. Singer, B.M. Howard, A.C. Johnson, C.J. Knowles, S. Jackman, C. Accinelli, A. Barra Caracciolo, I. Bernard, S. Bird, T. Boucard, A. Boxall, J.V. Brian, E. Cartmell, C. Chubb, J. Churchley, S. Costigan, M. Crane, M.J. Dempsey, B. Dorrington, B. Ellor, J. Fick, J. Holmes, T. Hutchinson, F. Karcher, S.L. Kelleher, P. Marsden, G. Noone, M.A. Nunn, J. Oxford, T. Rachwal, N. Roberts, M. Roberts, M.L. Sacc, M. Sanders, J.r.O. Straub, A. Terry, D. Thomas, S. Toovey, R. Townsend, N. Voulvoulis, and C. Watts Meeting report: risk assessment of Tamiflu use under pandemic conditions Environ Health Perspect 116 2008
36. ®) and loss of nutrient removal performance FEMS Microbiology Letters 315 2011 17 22
37. H. Söderström, J.D. Järhult, B. Olsen, R.H. Lindberg, H. Tanaka, and J. Fick Detection of the antiviral drug oseltamivir in aquatic environments PLoS ONE 4 2009 e6064
38. ®) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions Ecotoxicology and Environmental Safety 72 2009 1625 1634
39. M. Stumpf, T.A. Ternes, R.-D. Wilken, R. Silvana Vianna, and W. Baumann Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil The Science of the Total Environment 225 1999 135 141 (Pubitemid 29148053)
40. WHO WHO Rapid Advice Guidelines on Pharmacological Management of Humans Infected with Avian Influenza A (H5N1) Virus 2006 http://www.who.int/csr/ disease/avian-influenza/guidelines/pharmamanagement/en/index.html (accessed 01.12.10.), pp. 1-136
41. S.G. Zimmermann, M. Wittenwiler, J. Hollender, M. Krauss, C. Ort, H. Siegrist, and U. von Gunten Kinetic assessment and modeling of an ozonation step for full-scale municipal wastewater treatment: micropollutant oxidation, by-product formation and disinfection Water Research 45 2011 605 617